Patient recruitment at the speed of science

Learn how Sermonix Pharmaceuticals partnered with Tempus and its TIME network of clinical sites to accelerate patient recruitment for a phase 2 study.

Sep 20, 2022
Life Sciences
Clinical Trials
Oncology
Article
Sibel Blau, MDPresident and CEO, Quality Cancer Care Alliance Network, Medical Director, Northwest Medical Specialties
Matthew Cooney, MDVice President, Therapeutic Development, Tempus

Related content

White abstract folded triangle shape, pointing right, on a black background.Video
Abstract rings of light on a pale gradient beneath the words “With Tempus, you can move faster.”

The Tempus Data Advantage

2026-09-30
Life Sciences
Pan-Cancer
RWD
White abstract folded triangle shape, pointing right, on a black background.Video
A survival analysis chart beneath the words “embrace the modalities that matter.”

The Next Era of Precision Medicine

2026-09-29
Life Sciences
A white circle partially overlapping a solid white square against a dark background.Case Study
Case study: Real-world evidence in action: A validated survival endpoint and genomic predictors of T-DXd response.

Real-world evidence in action: A validated survival endpoint and genomic predictors of T-DXd response

2026-09-24
Life Sciences
Breast
RWD